The Protein Arginine Methyltransferases 1 and 5 affect Myc properties in glioblastoma stem cells

Published on Nov 4, 2019in Scientific Reports3.998
· DOI :10.1038/S41598-019-52291-6
Annarita Favia8
Estimated H-index: 8
(National Research Council),
Luisa Salvatori17
Estimated H-index: 17
(National Research Council)
+ 8 AuthorsBarbara Illi21
Estimated H-index: 21
(National Research Council)
Sources
Abstract
Protein Arginine (R) methylation is the most common post-translational methylation in mammalian cells. Protein Arginine Methyltransferases (PRMT) 1 and 5 dimethylate their substrates on R residues, asymmetrically and symmetrically, respectively. They are ubiquitously expressed and play fundamental roles in tumour malignancies, including glioblastoma multiforme (GBM) which presents largely deregulated Myc activity. Previously, we demonstrated that PRMT5 associates with Myc in GBM cells, modulating, at least in part, its transcriptional properties. Here we show that Myc/PRMT5 protein complex includes PRMT1, in both HEK293T and glioblastoma stem cells (GSCs). We demonstrate that Myc is both asymmetrically and symmetrically dimethylated by PRMT1 and PRMT5, respectively, and that these modifications differentially regulate its stability. Moreover, we show that the ratio between symmetrically and asymmetrically dimethylated Myc changes in GSCs grown in stem versus differentiating conditions. Finally, both PRMT1 and PRMT5 activity modulate Myc binding at its specific target promoters. To our knowledge, this is the first work reporting R asymmetrical and symmetrical dimethylation as novel Myc post-translational modifications, with different functional properties. This opens a completely unexplored field of investigation in Myc biology and suggests symmetrically dimethylated Myc species as novel diagnostic and prognostic markers and druggable therapeutic targets for GBM.
📖 Papers frequently viewed together
11 Authors (Guozhen Gao, ..., Han Xu)
27 Citations
20124.39FEBS Journal
11 Authors (Jing Zhong, ..., Gebo Wen)
42 Citations
References46
Newest
#1Yeshavanth Kumar Banasavadi-Siddegowda (OSU: Ohio State University)H-Index: 12
#2Alessandra M. Welker (OSU: Ohio State University)H-Index: 7
Last. Balveen Kaur (OSU: Ohio State University)H-Index: 45
view all 15 authors...
Background: In spite of standard multimodal therapy consisting of surgical resection followed by radiation and concurrent chemotherapy, prognosis for glioblastoma (GBM) patients remains poor. The identification of both differentiated and undifferentiated "stem cell like" populations in the tumor highlights the significance of finding novel targets that affect the heterogeneous tumor cell population. Protein arginine methyltransferase 5 (PRMT5) is one such candidate gene whose nuclear expression ...
27 CitationsSource
#1Youli Zhang (Jiangsu University)H-Index: 11
#2Dawei Wang (Jiangsu University)H-Index: 6
Last. Min Xu (Jiangsu University)H-Index: 16
view all 13 authors...
Abstract Protein arginine methyltransferase 1 (PRMT1) is up-regulated and promotes migration, invasion and proliferation in wide range of cancers. However, we for the first time identify that PRMT1 promotes migration and invasion and inhibits proliferation in gastric cancer cells, a phenomenon called “migration-proliferation dichotomy”. First, we find that PRMT1 overexpression promotes migration and invasion and inhibits proliferation, whereas PRMT1 knockdown reverses the above abilities. Next, ...
7 CitationsSource
#1Simona Infantino (Monash University)H-Index: 8
#2Amanda Light (University of Melbourne)H-Index: 20
Last. David M. Tarlinton (Monash University)H-Index: 64
view all 11 authors...
Arginine methylation catalyzed by protein arginine methyltransferases (PRMT) is a common post-translational modification in mammalian cells, regulating many important functions including cell signalling, proliferation and differentiation. Here we show the role of PRMT1 in B-cell activation and differentiation. PRMT1 expression and activity in human and mouse peripheral B cells increases in response to in vitro or in vivo activation. Deletion of the Prmt1 gene in mature B cells establishes that a...
14 CitationsSource
#1Kai Zhao (Tianjin Medical University General Hospital)H-Index: 4
#2Qixue Wang (Tianjin Medical University General Hospital)H-Index: 17
Last. Chunsheng Kang (Tianjin Medical University General Hospital)H-Index: 54
view all 8 authors...
Abstract The epidermal growth factor receptor (EGFR) frequently undergoes high-level genomic amplification and variant III (vIII) deletion in adult glioblastoma. MicroRNAs (miRNAs) are recognized to participate in gene expression regulation. We found that miR-524-3p and miR-524-5p were suppressed in the classical molecular subtype of glioblastoma (GBM) from Chinese Glioma Genome Atlas (CGGA) data, and the suppression was associated with EGFR overexpression and EGFRvIII mutation. These two miRNAs...
27 CitationsSource
#1Mizuki Honda (Kyushu University)H-Index: 2
#2Kinichi Nakashima (Kyushu University)H-Index: 56
Last. Sayako Katada (Kyushu University)H-Index: 11
view all 3 authors...
Arginine methylation is a posttranslational modification which is catalyzed by protein arginine methyltransferases (PRMTs). Here, we report that PRMT1 is highly expressed in neural stem/precursor cells (NS/PCs) of mouse embryos, and knockdown of PRMT1 in NS/PCs suppresses the generation of astrocytes. The luciferase assay demonstrated that knockdown of PRMT1 inhibits activation of the promoter of a typical astrocytic marker gene, glial fibrillary acidic protein (Gfap), in NS/PCs. The transcripti...
10 CitationsSource
#1Corina T. Madreiter-Sokolowski (Medical University of Graz)H-Index: 14
#2Balázs GyőrffyH-Index: 34
Last. Wolfgang F. Graier (Medical University of Graz)H-Index: 51
view all 8 authors...
// Corina T. Madreiter-Sokolowski 1 , Balazs Győrffy 3,4 , Christiane Klec 1 , Armin A. Sokolowski 2 , Rene Rost 1 , Markus Waldeck-Weiermair 1 , Roland Malli 1 and Wolfgang F. Graier 1 1 Institute of Molecular Biology and Biochemistry, Medical University of Graz, Graz, Austria 2 Dentistry and Maxillofacial Surgery, Medical University of Graz, Graz, Austria 3 MTA TTK Lendulet Cancer Biomarker Research Group, Institute of Enzymology, Budapest, Hungary 4 2nd Department of Pediatrics, Semmelweis Un...
10 CitationsSource
#1Irina TikhanovichH-Index: 12
#2Jie ZhaoH-Index: 9
Last. Steven A. WeinmanH-Index: 38
view all 6 authors...
: Protein arginine methyltransferase 1 (PRMT1) is an essential enzyme controlling about 85% of the total cellular arginine methylation in proteins. We have shown previously that PRMT1 is an important regulator of innate immune responses and that it is required for M2 macrophage differentiation. c-Myc is a transcription factor that is critical in regulating cell proliferation and also regulates the M2 transcriptional program in macrophages. Here, we sought to determine whether c-Myc in myeloid ce...
13 CitationsSource
#1Luciana Rodrigues Gomes (Albert Einstein College of Medicine)H-Index: 10
#2Carlo Frederico Martins Menck (USP: University of São Paulo)H-Index: 1
Last. Ana Maria Cuervo (Albert Einstein College of Medicine)H-Index: 104
view all 3 authors...
ABSTRACTChaperone-mediated autophagy (CMA), a selective form of protein lysosomal degradation, is maximally activated in stress situations to ensure maintenance of cellular homeostasis. CMA activity decreases with age and in several human chronic disorders, but in contrast, in most cancer cells, CMA is upregulated and required for tumor growth. However, the role of CMA in malignant transformation remains unknown. In this study, we demonstrate that CMA inhibition in fibroblasts augments the effic...
38 CitationsSource
#1Roméo Sébastien Blanc (McGill University)H-Index: 4
#2Gillian Vogel (McGill University)H-Index: 12
Last. Stéphane Richard (McGill University)H-Index: 69
view all 6 authors...
: Quiescent muscle stem cells (MSCs) become activated in response to skeletal muscle injury to initiate regeneration. Activated MSCs proliferate and differentiate to repair damaged fibers or self-renew to maintain the pool and ensure future regeneration. The balance between self-renewal, proliferation, and differentiation is a tightly regulated process controlled by a genetic cascade involving determinant transcription factors such as Pax7, Myf5, MyoD, and MyoG. Recently, there have been several...
30 CitationsSource
#1Yeshavanth Kumar Banasavadi-Siddegowda (OSU: Ohio State University)H-Index: 12
#2Luke Russell (OSU: Ohio State University)H-Index: 7
Last. Balveen Kaur (OSU: Ohio State University)H-Index: 45
view all 11 authors...
PRMT5–PTEN molecular pathway regulates senescence and self-renewal of primary glioblastoma neurosphere cells
53 CitationsSource
Cited By9
Newest
#1Jean-Paul Bryant (NIH: National Institutes of Health)H-Index: 1
#2John D. Heiss (NIH: National Institutes of Health)H-Index: 35
Last. Yeshavanth Kumar Banasavadi-Siddegowda (NIH: National Institutes of Health)H-Index: 12
view all 3 authors...
Protein arginine methylation is a common post-translational modification that plays a pivotal role in cellular regulation. Protein arginine methyltransferases (PRMTs) catalyze the modification of target proteins by adding methyl groups to the guanidino nitrogen atoms of arginine residues. Protein arginine methylation takes part in epigenetic and cellular regulation and has been linked to neurodegenerative diseases, metabolic diseases, and tumor progression. Aberrant expression of PRMTs is associ...
1 CitationsSource
#1Sabrina Francesca Samuel (University of Hull)H-Index: 2
#2Antonia Barry (University of Hull)H-Index: 1
Last. Pedro Beltran-Alvarez (University of Hull)H-Index: 13
view all 4 authors...
Despite intense research efforts, our pharmaceutical repertoire against high-grade brain tumours has not been able to increase patient survival for a decade and life expectancy remains at less than 16 months after diagnosis, on average. Inhibitors of protein arginine methyltransferases (PRMTs) have been developed and investigated over the past 15 years and have now entered oncology clinical trials, including for brain tumours. This review collates recent advances in the understanding of the role...
1 CitationsSource
#1Homa Fatma (AMU: Aligarh Muslim University)H-Index: 2
#2Santosh K Maurya (AMU: Aligarh Muslim University)H-Index: 1
Last. Hifzur R. Siddique (AMU: Aligarh Muslim University)H-Index: 19
view all 3 authors...
1 CitationsSource
#1Enrico Lattuada (Sapienza University of Rome)H-Index: 3
#2Manuela Leo (Sapienza University of Rome)H-Index: 4
Last. Patrizia Filetici (Sapienza University of Rome)H-Index: 21
view all 7 authors...
2 CitationsSource
#1Nan-Nan ZhengH-Index: 2
#2Min ZhouH-Index: 6
Last. Lei-Ming XuH-Index: 12
view all 8 authors...
BACKGROUND Immunotherapy targeting programmed death-1 (PD-1) or programmed death-ligand-1 (PD-L1) has been shown to be effective in a variety of malignancies but has poor efficacy in pancreatic ductal adenocarcinoma (PDAC). Studies have shown that PD-L1 expression in tumors is an important indicator of the efficacy of immunotherapy. Tumor cells usually evade chemotherapy and host immune surveillance by epigenetic changes. Protein arginine methylation is a common posttranslational modification. P...
2 CitationsSource
#1Zhong Yan Hua (UR: University of Rochester)H-Index: 1
#2Jeanne N. Hansen (UR: University of Rochester)H-Index: 2
Last. Xingguo Li (UR: University of Rochester)H-Index: 10
view all 22 authors...
Aberrant expression of protein arginine methyltransferases (PRMTs) has been implicated in a number of cancers, making PRMTs potential therapeutic targets. But it remains not well understood how PRMTs impact specific oncogenic pathways. We previously identified PRMTs as important regulators of cell growth in neuroblastoma, a deadly childhood tumor of the sympathetic nervous system. Here, we demonstrate a critical role for PRMT1 in neuroblastoma cell survival. PRMT1 depletion decreased the ability...
1 CitationsSource
#1Ming Liu (NU: Nanjing University)H-Index: 7
#2Bing Yao (Nanjing Medical University)H-Index: 5
Last. Quan Zhao (NU: Nanjing University)H-Index: 13
view all 21 authors...
: The proto-oncogene c-Myc regulates multiple biological processes mainly through selectively activating gene expression. However, the mechanisms underlying c-Myc-mediated gene repression in the context of cancer remain less clear. This study aimed to clarify the role of PRMT5 in the transcriptional repression of c-Myc target genes in gastric cancer. Methods: Immunohistochemistry was used to evaluate the expression of PRMT5, c-Myc and target genes in gastric cancer patients. PRMT5 and c-Myc inte...
6 CitationsSource
#1Pamela Bielli (University of Rome Tor Vergata)H-Index: 17
#2Vittoria Pagliarini (UCSC: Catholic University of the Sacred Heart)H-Index: 1
Last. Claudio SetteH-Index: 50
view all 5 authors...
Brain tumors are a heterogeneous group of neoplasms ranging from almost benign to highly aggressive phenotypes. The malignancy of these tumors mostly relies on gene expression reprogramming, which is frequently accompanied by the aberrant regulation of RNA processing mechanisms. In brain tumors, defects in alternative splicing result either from the dysregulation of expression and activity of splicing factors, or from mutations in the genes encoding splicing machinery components. Aberrant splici...
10 CitationsSource